Press Releases

Media Focus

Successful development and manufacturing of complex biologics with integrated CMC solutions

Media Focus - Successful development and manufacturing of complex biologics with integrated CMC solutions

The complexity of new biologics means that these life-changing therapeutics require complicated development and manufacturing processes. Product-specific chemistry, manufacturing and controls (CMC) platforms are required at all stages throughout the development of biologics. By partnering with external organizations that offer integrated CMC solutions, biopharma companies can ensure the successful development and manufacturing of complex biologics and deliver therapies to patients sooner. 

 

In this article, Jiwoo Bae, Senior Scientist in Complex Antibody Downstream Process at Samsung Biologics, explores how integrated CMC solutions can bring success to the development and manufacturing of complex biologics. She shares unique insights into the evolution of biologics, the rising demand for more complex therapies and hitting key development milestones, with information on how integrated CMC platforms can bring these areas together and deliver successful biologics development and manufacturing.

Read more  

Media Focus - Successful development and manufacturing of complex biologics with integrated CMC solutions

The complexity of new biologics means that these life-changing therapeutics require complicated development and manufacturing processes. Product-specific chemistry, manufacturing and controls (CMC) platforms are required at all stages throughout the development of biologics. By partnering with external organizations that offer integrated CMC solutions, biopharma companies can ensure the successful development and manufacturing of complex biologics and deliver therapies to patients sooner. 

 

In this article, Jiwoo Bae, Senior Scientist in Complex Antibody Downstream Process at Samsung Biologics, explores how integrated CMC solutions can bring success to the development and manufacturing of complex biologics. She shares unique insights into the evolution of biologics, the rising demand for more complex therapies and hitting key development milestones, with information on how integrated CMC platforms can bring these areas together and deliver successful biologics development and manufacturing.

Read more

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION